Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 1
2005 1
2006 1
2007 5
2008 3
2009 4
2010 1
2011 4
2012 2
2013 11
2014 7
2015 5
2016 3
2017 8
2018 13
2019 11
2020 12
2021 13
2022 7
2023 13
2024 8
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA, Wright S; Cannabidiol in Dravet Syndrome Study Group. Devinsky O, et al. N Engl J Med. 2017 May 25;376(21):2011-2020. doi: 10.1056/NEJMoa1611618. N Engl J Med. 2017. PMID: 28538134 Free article. Clinical Trial.
CACNA1A-associated epilepsy: Electroclinical findings and treatment response on seizures in 18 patients.
Le Roux M, Barth M, Gueden S, Desbordes de Cepoy P, Aeby A, Vilain C, Hirsch E, de Saint Martin A, Portes VD, Lesca G, Riquet A, Chaton L, Villeneuve N, Villard L, Cances C, Valton L, Renaldo F, Vermersch AI, Altuzarra C, Nguyen-Morel MA, Van Gils J, Angelini C, Biraben A, Arnaud L, Riant F, Van Bogaert P. Le Roux M, et al. Among authors: cances c. Eur J Paediatr Neurol. 2021 Jul;33:75-85. doi: 10.1016/j.ejpn.2021.05.010. Epub 2021 May 26. Eur J Paediatr Neurol. 2021. PMID: 34102571 Free article.
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial.
Crawford TO, Servais L, Mercuri E, Kölbel H, Kuntz N, Finkel RS, Krueger J, Batley K, Young SD, Marantz JL, Song G, Yao B, Zhao G, Rossello J, Tirucherai GS, Mazzone ES, Butterfield RJ, de la Banda MGG, Seferian AM, Sansone VA, De Waele L, van der Pol WL, Cances C, Pechmann A, Darras BT; SAPPHIRE Study Group. Crawford TO, et al. Among authors: cances c. Lancet Neurol. 2025 Sep;24(9):727-739. doi: 10.1016/S1474-4422(25)00225-X. Lancet Neurol. 2025. PMID: 40818473 Clinical Trial.
The Two Faces of Pediatric SCA2.
Rive Le Gouard N, G Bah M, Coarelli G, Heinzmann A, Fauret AL, de Sainte-Agathe JM, Cazeneuve C, Gerasimenko A, Gras D, Capri Y, Renaud M, Brais B, Grenenko C, Masurel A, Berquin P, Jobic F, Métreau J, Deiva K, Afenjar A, Gravrand V, Lannuzel A, Anheim M, Geis T, Hehr U, Madan Cohen J, Desnous B, J A Kievit A, Bahi-Buisson N, Rodriguez D, Renaldo F, Cances C, Devos D, Angelini C, Goizet C, Ewenczyk C, Durr A, Mignot C. Rive Le Gouard N, et al. Among authors: cances c. Eur J Neurol. 2025 Aug;32(8):e70314. doi: 10.1111/ene.70314. Eur J Neurol. 2025. PMID: 40741828 Free PMC article.
DMD Genotypes and Motor Function in Duchenne Muscular Dystrophy: A Multi-institution Meta-analysis With Implications for Clinical Trials.
Muntoni F, Signorovitch J, Sajeev G, Lane H, Jenkins M, Dieye I, Ward SJ, McDonald C, Goemans N, Niks EH, Wong B, Servais L, Straub V, Guglieri M, de Groot IJM, Chesshyre M, Tian C, Manzur AY, Mercuri E, Aartsma-Rus A; Association Française Contre Les Myopathies; on behalf of Universitaire Ziekenhuizen Leuven Group, PRO-DMD-01, The UK NorthStar Clinical Network, CCHMC, and The DMD Italian Group. Muntoni F, et al. Neurology. 2023 Apr 11;100(15):e1540-e1554. doi: 10.1212/WNL.0000000000201626. Epub 2023 Feb 1. Neurology. 2023. PMID: 36725339 Free PMC article.
[Benefit of treatment with rituximab in autoimmune myasthenia gravis in children].
Molimard A, Gitiaux C, Barnerias C, Audic F, Isapof A, Walther-Louvier U, Cances C, Espil-Taris C, Jean-Baptiste D, Quijano-Roy S, Grisel C, Chabrol B, Desguerre I. Molimard A, et al. Among authors: cances c. Med Sci (Paris). 2024 Nov;40 Hors série n° 1:22-25. doi: 10.1051/medsci/2024132. Epub 2024 Nov 18. Med Sci (Paris). 2024. PMID: 39555872 Review. French.
French National Protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD).
Attarian S, Beloribi-Djefaflia S, Bernard R, Nguyen K, Cances C, Gavazza C, Echaniz-Laguna A, Espil C, Evangelista T, Feasson L, Audic F, Zagorda B, Milhe De Bovis V, Stojkovic T, Sole G, Salort-Campana E, Sacconi S. Attarian S, et al. Among authors: cances c. J Neurol. 2024 Sep;271(9):5778-5803. doi: 10.1007/s00415-024-12538-3. Epub 2024 Jul 2. J Neurol. 2024. PMID: 38955828 Review.
125 results